MonumenTAL-3
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
Arms / Cohorts
Arm A:Investigational Medication, Daratumumab and Pomalidomide
Accepting patients
Arm B:Daratumumab, Pomalidomide and Dexamethasone
Accepting patients
Arm C:Investigational Medication and Daratumumab
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.